Department of Pediatrics, Division of Pediatric Endocrinology and Metabolism, Seoul National University Bundang Hospital, Seongnam, Korea.
Department of Pediatrics, Division of Pediatric Endocrinology and Metabolism, Seoul National University College of Medicine, Seoul, Korea.
PLoS One. 2023 Aug 18;18(8):e0290450. doi: 10.1371/journal.pone.0290450. eCollection 2023.
Imprinted genes are regulated by DNA methylation of imprinted differentially methylated regions (iDMRs). An increasing number of patients with congenital imprinting disorders (IDs) exhibit aberrant methylation at multiple imprinted loci, multi-locus imprinting disturbance (MLID). We examined MLID and its possible impact on clinical features in patients with IDs. Genome-wide DNA methylation analysis (GWMA) using blood leukocyte DNA was performed on 13 patients with Beckwith-Wiedemann syndrome (BWS), two patients with Silver-Russell syndrome (SRS), and four controls. HumanMethylation850 BeadChip analysis for 77 iDMRs (809 CpG sites) identified three patients with BWS and one patient with SRS showing additional hypomethylation, other than the disease-related iDMRs, suggestive of MLID. Two regions were aberrantly methylated in at least two patients with BWS showing MLID: PPIEL locus (chromosome 1: 39559298 to 39559744), and FAM50B locus (chromosome 6: 3849096 to 3849469). All patients with BWS- and SRS-MLID did not show any other clinical characteristics associated with additional involved iDMRs. Exome analysis in three patients with BWS who exhibited multiple hypomethylation did not identify any causative variant related to MLID. This study indicates that a genome-wide approach can unravel MLID in patients with an apparently isolated ID. Patients with MLID showed only clinical features related to the original IDs. Long-term follow-up studies in larger cohorts are warranted to evaluate any possible phenotypic consequences of other disturbed imprinted loci.
印迹基因受印迹差异甲基化区域(iDMR)的 DNA 甲基化调控。越来越多的先天性印迹障碍(IDs)患者在多个印迹基因座表现出异常甲基化,即多基因座印迹干扰(MLID)。我们研究了 MLID 及其对 IDs 患者临床特征的可能影响。对 13 例 Beckwith-Wiedemann 综合征(BWS)患者、2 例 Silver-Russell 综合征(SRS)患者和 4 名对照者的血液白细胞 DNA 进行了全基因组 DNA 甲基化分析(GWMA)。对 77 个 iDMR(809 个 CpG 位点)的 HumanMethylation850 BeadChip 分析发现,除了与疾病相关的 iDMR 外,还有 3 例 BWS 患者和 1 例 SRS 患者表现出额外的低甲基化,提示存在 MLID。至少有 2 例 BWS 患者存在 MLID 的两个区域发生异常甲基化:PPIEL 基因座(染色体 1:39559298 至 39559744)和 FAM50B 基因座(染色体 6:3849096 至 3849469)。所有存在 BWS-MLID 和 SRS-MLID 的患者均未表现出与其他涉及的 iDMR 相关的任何其他临床特征。对 3 例表现出多个低甲基化的 BWS 患者进行外显子组分析并未发现与 MLID 相关的任何致病变异。本研究表明,全基因组方法可揭示表现出明显孤立 ID 的患者中的 MLID。存在 MLID 的患者仅表现出与原始 IDs 相关的临床特征。需要对更大的队列进行长期随访研究,以评估其他受干扰印迹基因座的任何可能表型后果。